Citadel Advisors - ALZAMEND NEURO INC ownership

ALZAMEND NEURO INC's ticker is ALZN and the CUSIP is 02262M308. A total of 23 filers reported holding ALZAMEND NEURO INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ALZAMEND NEURO INC
ValueSharesWeighting
Q1 2023$7,565
-64.8%
17,800
-53.2%
0.00%
Q4 2022$21,466
-36.9%
38,000
+31.9%
0.00%
Q3 2022$34,000
-75.4%
28,800
-81.9%
0.00%
Q2 2022$138,000
+25.5%
159,446
+78.4%
0.00%
Q1 2022$110,000
-75.3%
89,400
-61.9%
0.00%
Q4 2021$445,000
-11.5%
234,400
+43.3%
0.00%
Q3 2021$503,000163,6250.00%
Other shareholders
ALZAMEND NEURO INC shareholders Q2 2022
NameSharesValueWeighting ↓
RFG Advisory, LLC 250,000$59,2500.00%
TRUIST FINANCIAL CORP 2,314,907$548,6330.00%
XTX Topco Ltd 12,974$3,0750.00%
UBS Group AG 7,927$1,8790.00%
IFP Advisors, Inc 5,000$1,1850.00%
OSAIC HOLDINGS, INC. 1,000$2370.00%
FMR LLC 268$640.00%
WELLS FARGO & COMPANY/MN 495$1170.00%
NORTHERN TRUST CORP 103,775$24,5950.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALZAMEND NEURO INC shareholders